Sandbox fungal meningitis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 24: | Line 24: | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''Followed By'' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''Followed By'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Fluconazole]] 800 mg/day''''' <BR>''OR''<BR>▸ '''''[[Itraconazole]] 200 mg bid or tid'''''<BR>''OR''<BR>▸ '''''[[Voriconazole]] 200–400 mg q12h''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Fluconazole]] 800 mg/day PO''''' <BR>''OR''<BR>▸ '''''[[Itraconazole]] 200 mg PO bid or tid'''''<BR>''OR''<BR>▸ '''''[[Voriconazole]] 200–400 mg IV q12h''''' | ||
|- | |- | ||
|} | |} |
Revision as of 19:40, 17 January 2014
Meningitis Main Page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Sheng Shi, M.D. [2]
fungal meningitis
Blastomyces
|